950160 on KOSDAQ

KOLON Tissuegene

Logo: tissuegene.com²

KOLON Tissuegene is an American cell and gene therapy company based in Rockville, founded in 1999.¹ It is part of KOLON Corporation.¹ Its shares trade on KOSDAQ under the symbol 950160.¹

Price unavailable

Last updated Oct 21, 2026.

Overview

Jun 9, 1999Founded¹

Compare with another stock.

Ticker950160 on KOSDAQ¹
Industrybiotechnology¹
HeadquartersRockville¹
Websitewww.tissuegene.com
Legal formcorporation¹

See how the biggest companies compare on our leaderboards

Image: tissuegene.com³

Corporate structure

KOLON Tissuegene is part of a group headed by KOLON Corporation. 11 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

KOLON Corporation Gwacheon, South Korea
- KOLON Tissuegene Rockville
- KOLON Global Subsidiary · Gwacheon, South Korea
- KOLON Industries Subsidiary · Gangseo District
  - Kolon BASF innoPOM Subsidiary · Gimcheon, South Korea
  - KOLON Investment Subsidiary · Gangnam District, South Korea
  - KOLON MATERIALS Subsidiary · Gwacheon, South Korea
- KOLON Life Science Subsidiary · Gangseo District
- KOLON Mobility Group Subsidiary · Songpa District, South Korea
- KOLON Pharma Subsidiary · Gwacheon, South Korea
- KOLON Spaceworks Subsidiary · Haman County, South Korea

Built from subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Subsidiaries and ownership

Parent company

KOLON Corporation

From Wikidata.¹

Timeline

Nov 6, 2017Went public Listed on KOSDAQ¹
Jun 9, 1999Founded Founded¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataKOLON Tissuegene on Wikidata
2
Company websiteKOLON Tissuegene logo
3
Company websiteKOLON Tissuegene photo